1
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
Condition(s):Geographic AtrophyLast Updated:March 6, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Geographic AtrophyLast Updated:March 6, 2019Terminated
Condition(s):Geographic AtrophyLast Updated:September 25, 2019Completed
Condition(s):Geographic AtrophyLast Updated:September 11, 2019Terminated
Condition(s):Geographic AtrophyLast Updated:October 15, 2019Terminated
Condition(s):Geographic AtrophyLast Updated:June 26, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.